292 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Article Searches
U.S. Stocks May See Further Downside In Early Trading https://www.rttnews.com/story.aspx?Id=3429912 Mar 05, 2024 - After ending the previous session modestly lower, stocks may see further downside in early trading on Tuesday. The major index futures are currently pointing to initial weakness on Wall Street, with the S&P 500 futures down by 0.4 percent.
Dave & Buster's (PLAY) Sees a More Significant Dip Than Broader Market: Some Facts to Know https://www.zacks.com/stock/news/2235661/dave-buster-s-play-sees-a-more-significant-dip-than-broader-market-some-facts-to-know?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6v1-2235661 Mar 04, 2024 - In the latest trading session, Dave & Buster's (PLAY) closed at $61.30, marking a -1.89% move from the previous day.
Capgemini: Good Cost Control, Still Seeing Slow Cycles, New GenAI Conversations https://seekingalpha.com/article/4675595-capgemini-good-cost-control-still-seeing-slow-cycles-new-genai-conversations?source=feed_all_articles Mar 03, 2024 - Capgemini is a tech consulting company with a focus on Europe and is preparing for better years driven by solid bookings. Read why CAPMF stock is a Hold.
U.S. Stocks Seeing Further Upside Amid Tech Sector Strength https://www.rttnews.com/story.aspx?Id=3429178 Mar 01, 2024 - Stocks have moved mostly higher during trading on Friday, with the Nasdaq and the S&P 500 on pace to set new record closing highs. The major averages have all moved to the upside, with the tech-heavy Nasdaq leading the advance. The advance by the Nasdaq partly reflects substantial strength among computer hardware stocks following upbeat results from Dell.
Wall Street Analysts See a 58.85% Upside in Arcutis Biotherapeutics, Inc. (ARQT): Can the Stock Really Move This High? https://www.zacks.com/stock/news/2234650/wall-street-analysts-see-a-58-85-upside-in-arcutis-biotherapeutics-inc-arqt-can-the-stock-really-move-this-high?cid=CS-ZC-FT-tale_of_the_tape|consensus_price_target-2234650 Mar 01, 2024 - The consensus price target hints at a 58.9% upside potential for Arcutis Biotherapeutics, Inc. (ARQT). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Wall Street Analysts See Arista Networks (ANET) as a Buy: Should You Invest? https://www.zacks.com/stock/news/2234548/wall-street-analysts-see-arista-networks-anet-as-a-buy-should-you-invest?cid=CS-ZC-FT-fundamental_analysis|average_broker_rating-2234548 Mar 01, 2024 - Based on the average brokerage recommendation (ABR), Arista Networks (ANET) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
Wall Street Analysts See ANI (ANIP) as a Buy: Should You Invest? https://www.zacks.com/stock/news/2234557/wall-street-analysts-see-ani-anip-as-a-buy-should-you-invest?cid=CS-ZC-FT-fundamental_analysis|average_broker_rating-2234557 Mar 01, 2024 - Based on the average brokerage recommendation (ABR), ANI (ANIP) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
Bitcoin ETFs see record-high trading volumes as retail investors jump on crypto rally https://www.cnbc.com/2024/02/28/bitcoin-etfs-see-record-high-trading-volumes-as-retail-investors-jump-on-crypto-rally.html Feb 28, 2024 - The iShares Bitcoin Trust (IBIT) has already seen a record number of shares traded on Wednesday.
Wall Street Analysts See Bitfarms Ltd. (BITF) as a Buy: Should You Invest? https://www.zacks.com/stock/news/2233166/wall-street-analysts-see-bitfarms-ltd-bitf-as-a-buy-should-you-invest?cid=CS-ZC-FT-fundamental_analysis|average_broker_rating-2233166 Feb 28, 2024 - Based on the average brokerage recommendation (ABR), Bitfarms Ltd. (BITF) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
Cracker Barrel CEO Julie Felss Masino sees a long road ahead as Q2 traffic dips 4% https://www.nrn.com/news/cracker-barrel-ceo-julie-felss-masino-sees-long-road-ahead-q2-traffic-dips-4 Feb 27, 2024 - The Tennessee-based casual-dining brand will focus on its new loyalty program, as well as strategic pricing and labor reductions, to improve the bottom line

Pages: 1...910111213141516171819...30

<<<Page 14>